19-1220700-G-C
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PS1PM1PM2PM5PP3_StrongPP5_Moderate
The NM_000455.5(STK11):c.717G>C(p.Trp239Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W239G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000455.5 missense
Scores
Clinical Significance
Conservation
Publications
- familial pancreatic carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Peutz-Jeghers syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| STK11 | NM_000455.5 | c.717G>C | p.Trp239Cys | missense_variant | Exon 5 of 10 | ENST00000326873.12 | NP_000446.1 | |
| STK11 | NM_001407255.1 | c.717G>C | p.Trp239Cys | missense_variant | Exon 5 of 9 | NP_001394184.1 | ||
| STK11 | NR_176325.1 | n.1984G>C | non_coding_transcript_exon_variant | Exon 6 of 11 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| STK11 | ENST00000326873.12 | c.717G>C | p.Trp239Cys | missense_variant | Exon 5 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
| STK11 | ENST00000652231.1 | c.717G>C | p.Trp239Cys | missense_variant | Exon 5 of 9 | ENSP00000498804.1 | ||||
| STK11 | ENST00000585748.3 | c.345G>C | p.Trp115Cys | missense_variant | Exon 7 of 12 | 3 | ENSP00000477641.2 | |||
| STK11 | ENST00000593219.6 | n.*542G>C | non_coding_transcript_exon_variant | Exon 6 of 11 | 3 | ENSP00000466610.1 | ||||
| STK11 | ENST00000593219.6 | n.*542G>C | 3_prime_UTR_variant | Exon 6 of 11 | 3 | ENSP00000466610.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Pathogenic:2
This sequence change replaces tryptophan with cysteine at codon 239 of the STK11 protein (p.Trp239Cys). The tryptophan residue is highly conserved and there is a large physicochemical difference between tryptophan and cysteine. This variant is not present in population databases (rs137853082, ExAC no frequency). This variant has been reported in two individuals affected with Peutz-Jeghers syndrome (PJS) (PMID: 12372054, 24054548). ClinVar contains an entry for this variant (Variation ID: 7458). An experimental study has shown that this missense change impairs the kinase function of STK11 by disrupting association with its binding partners STRAD and MO25 (PMID: 15561763). In addition, multiple PJS-associated missense mutations have been reported in this region, suggesting that this is an important domain for STK11 function (PMID: 20497868, 11389158, 17924967). For these reasons, this variant has been classified as Pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at